Plasminogen Activator Inhibitor‐1 and Diagnosis of the Metabolic Syndrome in a West African Population

BACKGROUND: Metabolic syndrome (MetS) is diagnosed by the presence of at least 3 of the following: obesity, hypertension, hyperglycemia, hypertriglyceridemia, and low high‐density lipoprotein. Individuals with MetS also typically have elevated plasma levels of the antifibrinolytic factor, plasminoge...

Descripción completa

Detalles Bibliográficos
Autores principales: Kodaman, Nuri, Aldrich, Melinda C., Sobota, Rafal, Asselbergs, Folkert W., Brown, Nancy J., Moore, Jason H., Williams, Scott M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5121488/
https://www.ncbi.nlm.nih.gov/pubmed/27697752
http://dx.doi.org/10.1161/JAHA.116.003867

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5121488/
https://www.ncbi.nlm.nih.gov/pubmed/27697752
http://dx.doi.org/10.1161/JAHA.116.003867

Ejemplares similares